Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study

Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Karch A, Mikolajczyk RT (2018)
BMC MEDICINE 16: 9.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ;
Abstract / Bemerkung
Background: Epidemiological studies suggest that reduced exposure to varicella might lead to an increased risk for herpes zoster (HZ). Reduction of exposure to varicella is a consequence of varicella vaccination but also of demographic changes. We analyzed how the combination of vaccination programs and demographic dynamics will affect the epidemiology of varicella and HZ in Germany over the next 50 years. Methods: We used a deterministic dynamic compartmental model to assess the impact of different varicella and HZ vaccination strategies on varicella and HZ epidemiology in three demographic scenarios, namely the projected population for Germany, the projected population additionally accounting for increased immigration as observed in 2015/2016, and a stationary population. Results: Projected demographic changes alone result in an increase of annual HZ cases by 18.3% and a decrease of varicella cases by 45.7% between 1990 and 2060. Independently of the demographic scenario, varicella vaccination reduces the cumulative number of varicella cases until 2060 by approximately 70%, but also increases HZ cases by 10%. Unlike the currently licensed live attenuated HZ vaccine, the new subunit vaccine candidate might completely counteract this effect. Relative vaccine effects were consistent across all demographic scenarios. Conclusion: Demographic dynamics will be a major determinant of HZ epidemiology in the next 50 years. While stationary population models are appropriate for assessing vaccination impact, models incorporating realistic population structures allow a direct comparison to surveillance data and can thus provide additional input for immunization decision-making and resource planning.
Erscheinungsjahr
Zeitschriftentitel
BMC MEDICINE
Band
16
Art.-Nr.
9
ISSN
PUB-ID

Zitieren

Horn J, Damm O, Greiner W, et al. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study. BMC MEDICINE. 2018;16: 9.
Horn, J., Damm, O., Greiner, W., Hengel, H., Kretzschmar, M. E., Siedler, A., Ultsch, B., et al. (2018). Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study. BMC MEDICINE, 16, 9. doi:10.1186/s12916-017-0983-5
Horn, J., Damm, O., Greiner, W., Hengel, H., Kretzschmar, M. E., Siedler, A., Ultsch, B., Weidemann, F., Wichmann, O., Karch, A., et al. (2018). Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study. BMC MEDICINE 16:9.
Horn, J., et al., 2018. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study. BMC MEDICINE, 16: 9.
J. Horn, et al., “Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study”, BMC MEDICINE, vol. 16, 2018, : 9.
Horn, J., Damm, O., Greiner, W., Hengel, H., Kretzschmar, M.E., Siedler, A., Ultsch, B., Weidemann, F., Wichmann, O., Karch, A., Mikolajczyk, R.T.: Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study. BMC MEDICINE. 16, : 9 (2018).
Horn, Johannes, Damm, Oliver, Greiner, Wolfgang, Hengel, Hartmut, Kretzschmar, Mirjam E., Siedler, Anette, Ultsch, Bernhard, Weidemann, Felix, Wichmann, Ole, Karch, Andre, and Mikolajczyk, Rafael T. “Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study”. BMC MEDICINE 16 (2018): 9.

25 References

Daten bereitgestellt von Europe PubMed Central.

[Demographic change and disease rates: a projection until 2050].
Peters E, Pritzkuleit R, Beske F, Katalinic A., Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 53(5), 2010
PMID: 20376420
Health and health-care systems in southeast Asia: diversity and transitions.
Chongsuvivatwong V, Phua KH, Yap MT, Pocock NS, Hashim JH, Chhem R, Wilopo SA, Lopez AD., Lancet 377(9763), 2011
PMID: 21269685
Estimating measles transmission potential in Italy over the period 2010-2011.
Ajelli M, Merler S, Fumanelli L, Bella A, Rizzo C., Ann. Ist. Super. Sanita 50(4), 2014
PMID: 25522076
The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study.
Marziano V, Poletti P, Guzzetta G, Ajelli M, Manfredi P, Merler S., Proc. Biol. Sci. 282(1804), 2015
PMID: 25761709
Herpes zoster in Germany: quantifying the burden of disease.
Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O., BMC Infect. Dis. 11(), 2011
PMID: 21679419
Modelling the impact of immunization on the epidemiology of varicella zoster virus.
Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G., Epidemiol. Infect. 125(3), 2000
PMID: 11218215
Modelling the impact of varicella vaccination on varicella and zoster.
Karhunen M, Leino T, Salo H, Davidkin I, Kilpi T, Auranen K., Epidemiol. Infect. 138(4), 2009
PMID: 19796447
Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data.
Guzzetta G, Poletti P, Del Fava E, Ajelli M, Scalia Tomba GP, Merler S, Manfredi P., Am. J. Epidemiol. 177(10), 2013
PMID: 23548754
Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?
Bilcke J, Ogunjimi B, Hulstaert F, Van Damme P, Hens N, Beutels P., Vaccine 30(17), 2011
PMID: 21964056
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barbera J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC; ZOE-50 Study Group, Arya M, Athan E, Cunningham AL, De Looze F, Seale JP, Yeo W, Goldani L, Jacob W, Luiz Neto J, dos Santos RR, Weckx L, Zerbini C, Dutz J, Ghesquiere W, Gorfinkel I, McElhaney JE, McNeil S, Powell C, Chlibek R, Smetana J, Poder A, Ahonen A, Korhonen T, Seppa I, Vesikari T, Arnou R, Beytout J, Saillard D, Dominicus R, Esen M, Plaßmann G, Schwarz T, Tyler K, Hui D, Leung E, Pellegrino A, Volpi A, Endo M, Watanabe D, Cheong HJ, Choi WS, Choo EJ, Kim YK, Lee JS, Park DW, Peck KR, Song YG, Barba-Gomez JF, de Los Santos AM, Tinoco JC, Bayas JM, Caso C, Roure JL, Via LM, Perez SN, Lopez CN, Puig-Barbera J, de la Pinta ML, Riera MT, Diez-Domingo J, Bengner M, Berglund J, Blom KB, Liu B, Pauksens K, Rombo L, Chen MF, Cheng HS, Hwang SJ, Liu CS, McNally D, Thompson A, Andrews C, Collins H, Downey H, Ervin J, Freedman M, Hoekstra J, Hull S, Levin M, Marcadis I, Rankin B, Van Cleeff M., N. Engl. J. Med. 372(22), 2015
PMID: 25916341
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barbera J, Vanden Abeele C, Vesikari T, Watanabe D, Zahaf T, Ahonen A, Athan E, Barba-Gomez JF, Campora L, de Looze F, Downey HJ, Ghesquiere W, Gorfinkel I, Korhonen T, Leung E, McNeil SA, Oostvogels L, Rombo L, Smetana J, Weckx L, Yeo W, Heineman TC; ZOE-70 Study Group, Athan E, Cunningham AL, de Looze F, Eizenberg P, Yeo W, Avelino-Silva TJ, Neto JL, Santos RR, Weckx L, Zerbini CA, Gauthier JS, Ghesquiere W, Gorfinkel I, McElhaney JE, McNeil SA, Toma A, Chlibek R, Smetana J, Poder A, Ahonen A, Forsten A, Karppa T, Korhonen T, Seppa I, Vesikari T, Esen M, Schwarz TF, Leung E, Desole MG, Icardi G, Pellegrino A, Staniscia T, Volpi A, Ikematsu H, Watanabe D, Choi WS, Barba-Gomez JF, Mascarenas de Los Santos A, Tinoco JC, Brotons C, Caso C, Diez-Domingo J, Narejos Perez S, Puig-Barbera J, Rodriguez de la Pinta ML, Berglund J, Blom KB, Liu B, Pauksens K, Rombo L, Hwang SJ, Thompson A, Andrews C, Jackson Downey H, Freedman M, Levin M, Arbi MB, Campora L, Catteau G, Curran D, Godeaux O, Heineman TC, Kovac M, Lal H, Marion S, Oostvogels L, Oujaa M, Ravault S, Abeele CV, Vastiau I, Zahaf T, Godeaux O, Heineman TC, Lal H, Zahaf T, Ahonen A, Andrews C, Athan E, Junqueira T, Barba-Gomez JF, Berglund J, Berndtsson Blom K, Brotons C, Caso C, Chlibek R, Choi WS, Cunningham AL, de Looze F, Diez-Domingo J, Downey H, Eizenberg P, Esen M, Forsten A, Freedman M, Gauthier JS, Ghesquiere W, Desole MG, Hwang SJ, Icardi G, Ikematsu H, Karppa T, Korhonen T, Liu B, Mascarenas de Los Santos A, McElhaney JE, McNeil SA, Narejos Perez S, Leung E, Neto JL, Pauksens K, Pellegrino A, Poder A, Puig-Barbera J, Santos RR, Rodriguez ML, Rombo L, Schwarz TF, Seppa I, Smetana J, Staniscia T, Thompson A, Tinoco JC, Toma A, Vesikari T, Volpi A, Weckx L, Yeo W, Zerbini C, Arbi MB, Catteau G, Curran D, Marion S, Oujaa M, Abeele CV, Zahaf T, Ahonen A, Athan E, Barba-Gomez JF, Campora L, Chlibek R, Cunningham AL, de Looze F, Diez-Domingo J, Jackson Downey H, Ghesquiere W, Godeaux O, Gorfinkel I, Heineman T, Hwang SJ, Korhonen T, Kovac M, Lal H, Leung E, Levin MJ, McElhaney JE, McNeil SA, Oostvogels L, Puig J, Ravault S, Rombo L, Smetana J, Abeele CV, Vastiau I, Vesikari T, Watanabe D, Weckx L, Yeo W, Zahaf T, Chlibek R, Cunningham AL, Diez-Domingo J, Heineman T, Hwang SJ, Kovac M, Lal H, Levin MJ, McElhaney JE, Oostvogels L, Puig-Barbera J, Heineman TC., N. Engl. J. Med. 375(11), 2016
PMID: 27626517
Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT., Hum Vaccin Immunother 12(7), 2016
PMID: 26835890
Social contacts and mixing patterns relevant to the spread of infectious diseases.
Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ., PLoS Med. 5(3), 2008
PMID: 18366252
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group., N. Engl. J. Med. 352(22), 2005
PMID: 15930418
Vaccination against Herpes Zoster and Postherpetic Neuralgia.
Oxman MN, Levin MJ; Shingles Prevention Study Group, Oxman MN, Arbeit RD, Barry P, Beisel C, Boardman KD, Colling CL, Davis LE, Gelb LD, Gershon AA, Hayward AR, Irwin MR, Johnson GR, Levin MJ, Peduzzi PN, Schmader KE, Simberkoff MS, Straus SE, Weinberg A, Williams HM, Annunziato P, Chan CY, Chan IS, Silber JL., J. Infect. Dis. 197 Suppl 2(), 2008
PMID: 18419402
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.
Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J., Clin. Infect. Dis. 54(7), 2012
PMID: 22291101

Baillot A, Toikkanen S, Monazahian M., 2016
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
Ultsch B, Damm O, Beutels P, Bilcke J, Bruggenjurgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O., Pharmacoeconomics 34(3), 2016
PMID: 26477039

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 29316913
PubMed | Europe PMC

Suchen in

Google Scholar